Ozempic: Miracle Weight Loss Drug Or A Secret Killer? - Johann Hari
Chris Williamson (host), Johann Hari (guest)
In this episode of Modern Wisdom, featuring Chris Williamson and Johann Hari, Ozempic: Miracle Weight Loss Drug Or A Secret Killer? - Johann Hari explores ozempic’s Promise And Peril: Weight-Loss Breakthrough Or Cultural Timebomb? Johann Hari discusses his year-long investigation into GLP-1 weight-loss drugs like Ozempic and Mounjaro, including his own dramatic weight loss using them. He explains how these drugs biologically work, their powerful health benefits, and the serious medical and psychological risks they may carry. The conversation links the obesity epidemic to ultra-processed food and explores whether pharmacological appetite suppression is an artificial fix for an artificial problem. Hari ultimately argues that using these drugs is a personal cost-benefit decision while warning of profound cultural, economic, and ethical consequences as their use scales globally.
Ozempic’s Promise And Peril: Weight-Loss Breakthrough Or Cultural Timebomb?
Johann Hari discusses his year-long investigation into GLP-1 weight-loss drugs like Ozempic and Mounjaro, including his own dramatic weight loss using them. He explains how these drugs biologically work, their powerful health benefits, and the serious medical and psychological risks they may carry. The conversation links the obesity epidemic to ultra-processed food and explores whether pharmacological appetite suppression is an artificial fix for an artificial problem. Hari ultimately argues that using these drugs is a personal cost-benefit decision while warning of profound cultural, economic, and ethical consequences as their use scales globally.
Key Takeaways
Using GLP-1s is a personal cost-benefit decision, not a simple fix.
Hari chose to stay on Ozempic because a ~20% reduction in heart attack and stroke risk outweighed the potential side effects for him, but emphasizes that others must weigh the known harms of obesity against still-uncertain long-term drug risks.
Get the full analysis with uListen AI
GLP-1 drugs change what you want, not just how much you eat.
These medications mimic the satiety hormone GLP-1 for a full week, acting not only on the gut but throughout the brain, radically dampening hunger and, for some, reshaping food preferences and eating speed.
Get the full analysis with uListen AI
Obesity is largely driven by ultra-processed foods that hijack satiety.
Hari cites research showing obesity skyrockets when societies switch from fresh, home-prepared foods to ultra-processed products that make it harder to feel full, making GLP-1s an artificial solution to a food-environment problem.
Get the full analysis with uListen AI
Most diets fail long-term because the brain defends a higher “set point” weight.
Evidence suggests that as people gain weight, their biological set point increases; when they diet, metabolism slows, cravings rise, and lethargy increases, making sustained loss rare and willpower alone an “umbrella in a storm.”
Get the full analysis with uListen AI
GLP-1s may influence broader compulsive behaviors, but evidence in humans is early.
Animal studies show sharp reductions in intake of alcohol, cocaine, heroin and fentanyl, and some patients report less compulsive shopping or smoking, but human trials so far are small and mixed, so claims of a “willpower drug” remain speculative.
Get the full analysis with uListen AI
The drugs carry serious specific risks that some people should avoid.
Concerns include elevated thyroid cancer signals in some data, muscle mass loss and future sarcopenia, potential birth defects if used in pregnancy, and strong warnings from eating-disorder experts about enabling extreme malnutrition in vulnerable young people.
Get the full analysis with uListen AI
Even if GLP-1s work medically, society still must fix the food environment.
Hari argues that a best-case future combines smart use of these drugs for those who need them with structural changes—like Japan’s—to prevent the next generation from ever needing a pharmacological escape from an obesogenic culture.
Get the full analysis with uListen AI
Notable Quotes
“These drugs are an artificial solution for an artificial problem.”
— Johann Hari
“Your brain hates it when you lose weight and will fight to drag you back to your highest weight.”
— Johann Hari (paraphrasing Dr. Giles Yeo)
“We’ve got to live in reality. If the solution was to just urge fat people to have more willpower, there wouldn’t be a fat person left.”
— Johann Hari
“It turns out that willpower is just a drug and the dosage is around about 0.5 milligrams per day.”
— Chris Williamson (quoting a friend on tirzepatide)
“For a lot of us, we’re in a trap, and this is the rusty, risky trapdoor we’re being offered.”
— Johann Hari
Questions Answered in This Episode
If GLP-1s primarily work in the brain, what unintended psychological or cognitive effects might only emerge after decades of widespread use?
Johann Hari discusses his year-long investigation into GLP-1 weight-loss drugs like Ozempic and Mounjaro, including his own dramatic weight loss using them. ...
Get the full analysis with uListen AI
How far should regulators go in restricting access (e.g., banning telehealth prescriptions) to protect people with or at risk of eating disorders?
Get the full analysis with uListen AI
Could governments justifiably use policy levers (taxes, reformulation, marketing limits) to reduce ultra-processed foods, knowing that GLP-1s exist as a powerful downstream fix?
Get the full analysis with uListen AI
At what BMI or risk profile, if any, would it be unethical for a clinician not to offer GLP-1 treatment given the known harms of long-term obesity?
Get the full analysis with uListen AI
How might mass adoption of GLP-1s reshape beauty standards, gender pressures, and stigma around both obesity and thinness over the next 10–20 years?
Get the full analysis with uListen AI
Transcript Preview
Johann Hari, welcome to the show.
Hey, Chris. Great to be with you again.
How are you? You've lost a lot of weight.
I have. I've lost, what I believe the technical term is a shitload of weight. I've lost three stone. I'm good. I'm cheerful. Life is good. Can't complain.
Talk to me about where this weight loss has come from.
Well, I remember the exact moment it all began. It was the winter of 2022, and I got invited to a party, and it was that moment, I hadn't been to a party in whatever it was, a year and a half, two years, 'cause the world was shut down. And I thought, "Fuck it, I'm gonna go to this party." And I was in the Uber on the way there, and I felt a little bit self-conscious 'cause I'd gained a load of weight, and I was quite fat at the start, and I'd gained a load of weight. And the party was being thrown by an Oscar-winning actor. I'm not saying that just to name drop. It's relevant to what happened next. And on the way there, I was both feeling this kind of like, ugh, bit schlubby and embarrassed, but I also thought, "Oh, wait, everyone I know gained weight during lockdown. This is gonna be fascinating. It's gonna be super interesting to see these Hollywood people with a bit of podge on them." And I arrived, and it was the weirdest sensation. It's not just that they hadn't gained weight. Everyone was gaunt, right? Everyone had lost, visibly lost weight. They looked like their own Snapchat filters. Do you know what I mean? They were, like, sharper and clearer. And I was stumbling around in a bit of a daze, and I bumped into an old friend of mine on the dance floor, and I, I said to her, "Shit, looks like everyone really did take up Pilates during lockdown, huh?" And she laughed at me, and I- I didn't know why she was laughing. I must have done a kind of strange face! And she said, "Well, Johann, you know it wasn't Pilates, right?" And she pulled up on her phone an image of an Ozempic pen. So, I did not know at that point that we now have a new kind of weight loss drug that works in a totally new way that causes people to lose 15% of their body weight. For the next version of this class of drug, Mounjaro, you lose 21% of your body weight, and for the next one, triple G, that will probably come online next year, people lose 24% of their body weight. And when I started to learn about this, I don't remember any subject in my whole life, actually, where I immediately felt so divided about it. So, I could obviously see the importance of it straight away, right? I knew even then that obesity is really bad for your health. You know, it makes over 200 diseases and complications more likely. And this wasn't an abstract question for me. I'm older than my grandfather ever got to be, 'cause he died of a heart attack when he was 44. My dad had very bad heart problems. My uncle died of a heart attack. Men on both sides of my family. So I thought, "Okay, if there's a drug that reverses or massively reduces obesity, that's a big deal." I also thought, "Come on now. Can you really have such a thing as a free lunch?" I guess with Ozempic it'd be a smaller free lunch. I thought, "I've seen this story before, right?" Every 20 years or so, going right back to the First World War, a new miracle diet drug is announced, and people stampede to get it. They take it in huge numbers, and we always discover it causes some horrendous dark side effect, and it has to be yanked from the market, leaving a trail of, you know, devastated people in its wake. And I was worried about lots of things. So, really, to get to the bottom of this, for a year I took the drug, and I went on a big journey all over the world, from Iceland to Minneapolis to Tokyo, to interview huge array of people on this, the biggest defenders of the drugs, including the people who made the breakthroughs that made it possible, the biggest critics of the drugs, everyone in between. And it's a weird thing that I'm sure will come out in our conversation, Chris. I learned a huge amount about the extraordinary benefits and the 12 disturbing risks of these drugs. Um, I learned that, about the incredible effects it's gonna have on the culture, including the people who don't even wanna take these drugs. But I'm s- gotta admit, I'm still pretty conflicted. It's actually a pretty complicated picture, where people are gonna have to weigh for themselves the, the benefits and the risks.
Install uListen to search the full transcript and get AI-powered insights
Get Full TranscriptGet more from every podcast
AI summaries, searchable transcripts, and fact-checking. Free forever.
Add to Chrome